Unknown OBSERVATIONAL NCT00457236

Effect of Clopidogrel Loading and Risk of PCI (EXCELSIOR)

Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement

Sponsor: University Heart Center Freiburg - Bad Krozingen

Conditions Coronary Artery Disease Drug Resistance

Updated 7 times since 2017 Last updated: Apr 5, 2007 Started: Mar 31, 2003 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Coronary Artery Disease and Drug Resistance and is currently ongoing. University Heart Center Freiburg - Bad Krozingen leads this study, which shows 7 recorded versions since 2003 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Dec 2019 — Jan 2021 [monthly]

Unknown Status
Jun 2018 — Dec 2019 [monthly]

Unknown Status

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Mar 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Heart Center Freiburg - Bad Krozingen

Data source: University Heart Center Freiburg - Bad Krozingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bad Krozingen, Germany